Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial von McKenzie, R., Walker, R.I., Nabors, G.S., Verg, L.L. Van De, Carpenter, C., Gomes, G., Forbes, E., Tian, J.H., Yang, H.H., Pace, J.L., Jackson, W.J., Bourgeois, A.L.

Volltext

Modulating ongoing Th2-cell responses in experimental leishmaniasis von Nabors, G.S.

Volltext

The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy von Van Maaren, M.C., Hueting, T.A., van Uden, D.J.P., van Hezewijk, M., de Munck, L., Mureau, M.A.M., Seegers, P.A., Voorham, Q.J.M., Schmidt, M.K., Sonke, G.S., Groothuis-Oudshoorn, C.G.M., Siesling, S.

Volltext